Polymeric carriers: Role of geometry in drug delivery

Expert Opinion on Drug Delivery

Volumn 5, Issue 12, 2008, Pages 1283-1300

  Simone, Eric A ^a,b,c   Dziubla, Thomas D ^b,d   Muzykantov, Vladimir R ^a,b,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Formulation; Geometry; Micelle; Nano; Polymer

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CARBON NANOTUBE; CISPLATIN; COPOLYMER; DAPSONE; DENDRIMER; DOXORUBICIN; DRUG CARRIER; ENZYME; INDIUM 111; LIPOSOME; MACROGOL; MONOMER; NANOCARRIER; NANOPARTICLE; NANOTUBE; PACLITAXEL; POLYACRYLIC ACID; POLYANHYDRIDE; POLYCAPROLACTONE; POLYESTER; POLYLACTIC ACID; POLYMER; POLYSTYRENE; RITUXIMAB; SMALL INTERFERING RNA; UNINDEXED DRUG;

ACIDIFICATION; ANISOTROPY; BIOCOMPATIBILITY; BIODEGRADABILITY; CELL VACUOLE; CHEMICAL STRUCTURE; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG RESEARCH; DRUG SAFETY; DRUG STABILITY; DRUG TARGETING; DRUG TRANSPORT; DRUG UPTAKE; EMULSION; ENANTIOMER; ENCAPSULATION; GEOMETRY; HUMAN; HYDROLYSIS; HYDROPHILICITY; HYDROPHOBICITY; MICELLE; MICROFLUIDICS; MOLECULAR WEIGHT; NONHUMAN; PARTICLE SIZE; PHAGOCYTOSIS; PHYSICAL CHEMISTRY; REVIEW; RISK BENEFIT ANALYSIS; STRUCTURE ANALYSIS; SURFACE PROPERTY; SYNTHESIS;

CHEMISTRY, PHARMACEUTICAL; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG DESIGN; LIPOSOMES; MICELLES; NANOSTRUCTURES; POLYMERS;

EID: 58149186706     PISSN: 17425247     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425240802567846     Document Type: Review

References (99)

1. Lasic DD. Product review: doxorubicin in sterically stabilized liposomes. Nature 1996380(6574):561
2. Photos PJ, Bacakova L, Discher B, et al. Polymer vesicles in vivo: correlations with PEG molecular weight. J Control Rel 2003;90(3):323-34
3. Saad M, Garbuzenko OB, Ber E, et al. Receptor targeted polymers, dendrimers, liposomes: which nanocarrier is the most efficient for tumor-specific treatment and imaging? J Control Rel 2008;130(2):107-14
4. Predescu D, Paiade GE. Plasmalemmal vesicles represent the large pore system of continuous microvascular endothelium. Am J Physiol 1993;265(2 Pt 2):H725-33
5. Vallet-Regi M, Balas F, Arcos D. Mesoporous materials for drug delivery. Angew Chem Int Ed Engl 2007;46(40):7548-58
6. Neumaier CE, Baio G, Ferrini S, et al. MR and iron magnetic nanoparticles. Imaging opportunities in preclinical and translational research. Tumori 2008;94(2):226-33
7. Misra RD. Quantum dots for tumor-targeted drug delivery and cell imaging. Nanomedicine 2008;3(3):271-4
8. Dziubla TD, Karim A, Muzykantov VR. Polymer nanocarriers protecting active enzyme cargo against proteolysis. J Control Rel 2005;102(2):427-39
9. Muro S, Cui X, Gajewski C, et al. Slow intracellular trafficking of catalase nanoparticles targeted to ICAM-1 protects endothelial cells from oxidative stress. Am J Physiol Cell Physiol 2003;285(5):C1339-47
10. Muro S, Gajewski C, Koval M, Muzykantov VR. ICAM-1 recycling in endothelial cells: a novel pathway for sustained intracellular delivery and prolonged effects of drugs. Blood 2005;105(2):650-8
11. Muro S, Garnacho C, Champion JA, et al. Control of Endothelial Targeting and Intracellular Delivery of Therapeutic Enzymes by Modulating the Size and Shape of ICAM-1-targeted Carriers. Mol Ther 2008. p. 1450-8
12. Chambers E, Mitragotri S. Long circulating nanoparticles via adhesion on red blood cells: mechanism and extended circulation. Exp Biol Med (Maywood) 2007;232(7):958-66
13. Inoue K, Suzuki K, Nojima S. Morphology of lipid micelles containing lysolecithin. J Biochem 1977;81(4):1097-106
14. Yager P, Schoen PE. Formation of Tubules by a Polymerizable Surfactant. Mol Crystals Liquid Crystals 1984;106:371-81
15. Lee KC, Carlson PA, Goldstein AS, et al. Protection of a decapeptide from proteolytic cleavage by lipidation and self-assembly into high-axial-ratio microstructures: a kinetic and structural study. Langmuir 1999;15(17):5500-8
16. Papahadjopoulos D, Vail WJ, Jacobson K, Poste G. Cochleate lipid cylinders: formation by fusion of unilamellar lipid vesicles. Biochim Biophys Acta 1975;394(3):483-91
17. Janoff AS, Boni LT, Popescu MC, et al. Unusual lipid structures selectively reduce the toxicity of amphotericin B. Proc Natl Acad Sci USA 1988;85(16):6122-6
18. Hayes MA, Pysher MD, Chen K. Liposomes form nanotubules and long range networks in the presence of electric field. J Nanosci Nanotechnol 2007;7(7):2283-6
19. Champion JA, Mitragotri S. Role of target geometry in phagocytosis. Proc Natl Acad Sci USA 2006;103(13):4930-4
20. Champion JA, Karate YK, Mitragotri S. Making polymeric micro- and nanoparticles of complex shapes. Proc Natl Acad Sci USA 2007;104(29):11901-4
21. Ho CC, Keller A, Odell JA, Ottewill RH. Preparation of monodisperse ellipsoidal polystyrene particles. Colloids Polym Sci 1993;271(5):469-79
22. Champion JA, Karate YK, Mitragotri S. Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers. J Control Release 2007;121(1-2):3-9
23. Xu S, Nie Z, Seo M, et al. Generation of monodisperse particles by using microfluidics: control over size, shape, and composition. Angew Chem Int Ed Engl 2005;44(5):724-8
24. Dendukuri D, Pregibon DC, Collins J, et al. Continuous-flow lithography for high-throughput microparticle synthesis. Nat Mater 2006;5(5):365-9
25. Gratton SE, Pohlhaus PD, Lee J, et al. Nanofabricated particles for engineered drug therapies: a preliminary biodiscribution study of PRINT nanoparticles. J Control Rel 2007;121(1-2):10-8
26. Gratton SE, Napier ME, Ropp PA, et al. Microfabricated Particles for Engineered Drug Therapies: Elucidation into the Mechanisms of Cellular Internalization of PRINT Particles. Pharm Res 2008
27. Discher DE, Eisenberg A. Polymer vesicles. Science 2002;297(5583):967-73
28. Jain S, Bates FS. On the origins of morphological complexity in block copolymer surfactants. Science 2003;300(5618):460-4
29. Lee JC, Bermudez H, Discher BM, et al. Preparation, stability, and in vitro performance of vesicles made with diblock copolymers. Biotechnol Bioeng 2001;73(2):135-45
30. Dalhaimer P, Bates FS, Discher DE. Single molecule visualization of stable, stiffness-tunable, flow-conforming worm micelles. Macromolecules 2003;36(18):6873-7
31. Bermudez H, Brannan AK, Hammer DA, et al. Molecular weight dependence of polymersome membrane structure, elasticity, and stability. Macromolecules 2002;35(21):8203-8
32. Ahmed F, Discher DE. Self-porating polymersomes of PEG-PLA and PEG-PCL: hydrolysis-triggered controlled release vesicles. J Control Release 2004;96(1):37-53
33. Geng Y, Dalhaimer P, Cai S, et al. Shape effects of filaments versus spherical particles in flow and drug delivery, Nat Nano 2007;2(4):249-55
34. Simone EA, Dziubla TD, Colon-Gonzalez F, et al. Effect of polymer amphiphilicity on loading of a therapeutic enzyme into protective filamentous and spherical polymer nanocarriers. Biomacromolecules 2007;8(12):3914-21
35. Zheng LX, O'Connell MJ, Doorn SK, et al. Ultralong single-wall carbon nanotubes. Nature Materials 2004;3(10):673-6
36. Pampaloni F, Florin EL. Microtubule architecture: inspiration for novel carbon nanotube-based biomimetic materials. Trends Biotechnol 2008;26(6):302-10
37. Bianco A, Kostarelos K, Prato M. Opportunities and challenges of carbon-based nanomaterials for cancer therapy. Expert Opin Drug Deliv 2008;5(3):331-42
38. Zarif L. Drug delivery by lipid cochleates. Methods Enzymol 2005;391:314-29
39. Sharkey PK, Graybill JR, Johnson ES, et al. Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS. Clin Infect Dis 1996;22(2):315-21
40. Petros RA, Ropp PA, DeSimone JM. Reductively labile PRINT particles for the delivery of doxorubicin to HeLa cells. J Am Chem Soc 2008;130(15):5008-9
41. Kelly JY, DeSimone JM. Shape-specific, monodisperse nano-molding of protein particles. J Am Chem Soc 2008;130(16):5438-9
42. Liggins RT Burt HM. Polyether-polyester diblock copolymers for the preparation of paclitaxel loaded polymeric micelle formulations. Adv Drug Deliv Rev 2002;54(2):191-202
43. Dalhaimer P, Engler AJ, Parthasarathy R, Discher DE. Targeted worm micelles. Biomacromolecules 2004;5(5):1714-9
44. Cai S, Vijayan K, Cheng D, et al. Micelles of Different Morphologies - Advantages of Worm-like Filomicelles of PEO-PCL in Paclitaxel Delivery. Pharm Res 2007;24(6):2099-109
45. Ahmed F, Pakunlu RI, Srinivas G, et al. Shrinkage of a rapidly growing tumor by drug-loaded polymersomes: pH-triggered release through copolymer degradation. Mol Pharm 2006;3(3):340-50
46. Accardo A, Tesaum D, Aloj L, et al. Peptide-containing aggregates as selective nanocarriers for therapeutics. ChemMedChem 2008;3(4):594-602
47. Hilder TA, Hill JM. Carbon nanotubes as drug delivery nanocapsules. Curr Appl Phys 2008;8(3-4):258-61
48. Popat KC, Eltgroth M, LaTempa TJ, et al. Titania nanombes: a novel platform for drug-eluting coatings for medical implants? Small 2007;3(11):1878-81
49. Garnacho C, Dhami R, Simone FA, et al. Delivery of Acid Sphingomyelinase in Normal and Niemann-Pick Disease Mice Using Intercellular Adhesion Molecule-1-Targeted Polymer Nanocarriers. J Pharmacol Exp Ther 2008;325 (2):400-8
50. Takagi A, Hirose A, Nishimura T, et al. Induction of mesothelioma in p53+/-mouse by intraperitoneal application of multi-wall carbon nanotube. J Toxicol Sci 2008;33(1):105-16
51. Tazawa H, Tatemichi M, Sawa T, et al. Oxidative and nitrative stress caused by subcutaneous implantation of a foreign body accelerates sarcoma development in Trp53+/-mice. Carcinogenesis 2007;28(1):191-8
52. Kumar N, Ravikumar MN, Domb AJ. Biodegradable block copolymers. Adv Drug Deliv Rev 2001;53(1):23-44
53. Shive MS, Anderson JM. Biodegradation and biocompadbility of PLA and PLGA microspheres. Adv Drug Deliv Rev 1997;28(1):5-24
54. Siepmann J, Gopferich A. Mathematical modeling of bioerodible, polymeric drug delivery systems. Adv Drug Deliv Rev 2001;48(2-3):229-47
55. Hanes J, Chiba M, Langer R. Synthesis and Characterization of Degradable Anhydride-co-imide Terpolymers Containing Trimellitylimido-L-Tyrosine: Novel Polym Drug Deliv Macromol 1996;29(16):5279-87
56. Leong KW, Brott BC, Langer R. Bioerodible polyanhydrides as drug-carrier matrices. I: Characterization, degradation, and release characteristics. J Biomed Mater Res 1985;19(8):941-55
57. Tabara Y, Gutta S, Langer R. Controlled delivery systems for proteins using polyanhydride microspheres. Pharm Res 1993;10(4):487-96
58. Jiang HL, Zhu KJ. Preparation, characterization and degradation characteristics of polyanhydrides containing poly(ethylene glycol). Polym Int 1999;48(1):47-52
59. Carino GP, Jacob JS, Mathiowitz E. Nanosphere based oral insulin delivery. J Control Release 2000;65(1-2):261-9
60. Fu J, Wu, Chi. Laser Light Scattering of the Degradation of Poly(sebacic anhydride) Nanoparticles. Journal of Polymer Science Part B: Polymer Physics 2001;39(6):703-9
61. Pfeifer BA, Burdick JA, Langer R. Formulation and surface modification of poly(ester-anhydride) micro- and nanospheres. Biomaterials 2005;26(2):117-24
62. Li S, Garreau H, Vert M. Structure-property relationships in the case of the degradation of solid aliphatic poty-(α-hydroxy acids) in aqueous media part 3: influence of the morphology of poly(L-lactic acid). J Matter Sci Mater Med 1990;1(4):198-206
63. Li S, Garreau H, Vert M. Structure-property relationships in the case of the degradation of solid aliphatic poly-(α-hydroxy acids) in aqueous media. Part 1 Poly(DL-lactic acid). J Matter Sci Mater Med 1990; 1(3):123
64. Duncan R. The dawning era of polymer therapeutics. Nat Rev Drug Discov 2003;2(5):347-60
65. Geng Y, Discher DE. Hydrolytic degradation of poly(ethylene oxide)-block-polycaprolactone worm micelles. J Am Chem Soc 2005;127(37):12780-1
66. Shih C. A graphical method for the determination of the mode of hydrolysis of biodegradable polymers. Pharm Res 1995;12(12):2036-60
67. Gopferich A. Mechanisms of polymer degradation and erosion. Biomaterials 1996;17(2):103-14
68. Li S, Molina I, Martinez MB, Vert M. Hydrolytic and enzymatic degradations of physically crosslinked hydrogels prepared from PLA/PEO/ PLA triblock copolymers. J Mater Sci Mater Med 2002;13(1):81-6
69. MacDonald RT, McCarthy SP, Gross RA. Enzymatic degradabiliry of poly(lactide): effects of chain stereochemistry and material crystallinity. Macromolecules 1996;29(23):7356-61
70. Tokiwa Y, Jarerat A. Biodegradation of poly(L-lactide). Biotechnol Lett 2004;26(10):771-7
71. Klibanov AL, Maruyama K, Torchilin VP, Huang L. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposornes. FEBS Lett 1990;268(1):235-7
72. Lee JC, Wong DT, Discher DE. Direct measures of large, anisotropic strains in deformation of the erythrocyte cytoskeleton. Biophys J 1999;77(2):853-64
73. Moghimi SM, Porter CJ, Muir IS, et al. Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating. Biochem Biophys Res Commun 1991;177(2):861-6
74. Singh R, Pantarotto D, Lacerda L, et al. Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. Proc Natl Acad Sci USA 2006;103(9):3357-62
75. Liu Z, Davis C, Cai W, et al. Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy. Proc Natl Acad Sci USA 2008;105(5):1410-5
76. Lacerda L, Ali-Boucetta H, Herrero MA, et al. Tissue histology and physiology following intravenous administration of different types of functionalized multiwalled carbon nanotubes. Nanomedicine 2008;3(2):149-61
77. Bedu-Addo FK, Tang P, Xu Y, Huang L. Interaction of polyethyleneglycol-phospholipid conjugates with cholesterol-phosphatidylcholine mixtures: sterically stabilized liposome formulations. Pharm Res 1996;13(5):718-24
78. Cato MH, D'Annibale F, Mills DM, et al. Cell-type specific and cytoplasmic targeting of PEGylated carbon nanotube-based nanoassemblies. J Nanosci Nanotechnol 2008;8(5):2259-69
79. McDevitt MR, Chattopadhyay D, Kappel BJ, et al. Tumor targeting with antibody-functionalized, radiolabeled carbon nanotubes. J Nucl Med 2007;48(7):1180-9
80. Garnacho C, Albelda SM, Muzykantov VR, Muro S. Differential intra-endothelial delivery of polymer nanocarriers targeted to distinct PECAM-1 epitopes. J Control Release 2008;130(3):226-33
81. Muzykantov VR. Targeting pulmonary endothelium. In: Muzykantov VRaT V, editor, Biomedical aspects of drug targeting. Boston: Kluwer Academic Publishers; 2003. p. 129-48
82. Lamaze C, Schmid SL. The emergence of clathrin-independent pinocytic pathways. Curr Opin Cell Biol 1995;7(4):573-80
83. Hewlett LJ, Prescott AR, Watts C. The coated pit and macropinocytic pathways serve distinct endosome populations. J Cell Biol 1994;124(5):689-703
84. Koval M, Preiter K, Adles C, et al. Size of IgG-opsonized particles determines macrophage response during internalization. Exp Cell Res 1998;242(1):265-73
85. Storrie B, Desjardins M. The biogenesis of lysosomes: is it a kiss and run, continuous fusion and fission process? Bioessays 1996;18(11):895-903
86. Brewer JM, Tetley L, Richmond J, et al. Lipid vesicle size determines the Th1 or Th2 response to entrapped antigen. J Immunol 1998;161(8):4000-7
87. Romero EL, MorillaMJ, Regts J, et al. On the mechanism of hepatic transendothelial passage of large liposomes. FEBS Lett 1999;448(1):193-6
88. Champion JA, Mitragotri S. Shape Induced Inhibition of Phagocytosis of Polymer Particles. Pharm Res 2008 [Epub ahead of print]
89. Caron E, Hall A. Phagocytosis: Oxford University Press, 2001
90. Sahagian GG, Steer CJ. Transmembrane orientation of the mannose 6-phosphate receptor in isolated clathrin-coated vesicles. J Biol Chem 1985;260(17):9838-42
91. Muro S, Wiewrodt R, Thomas A, et al. A novel endocytic pathway induced by clustering endothelial ICAM-1 or PECAM-1. J Cell Sci 2003;116(Pt 8):1599-609
92. Kok RJ, Everts M, Asgeirsdottir SA, et al. Cellular handling of a dexamethasone-anti-E-selectin immunoconjugate by activated endothelial cells: comparison with free dexamethasone. Pharm Res 2002;19(11):1730-5
93. Ricard I, Payer MD, Dupuis G. VCAM-1 is internalized by a clathrin-related pathway in human endothelial cells but its alpha 4 beta 1 integrin counter-receptor remains associated with the plasma membrane in human T lymphocytes. Eur J Immunol 1998;28(5):1708-18
94. Tsourkas A, Shinde-Patil VR, Kelly KA, et al. In vivo imaging of activated endothelium using an anti-VCAM-1 magnetooptical probe. Bioconjug Chem 2005;16(3):576-81
95. Fingar VH, Taber SW, Buschemeyer WC, et al. Constitutive and stimulated expression of ICAM-1 protein on pulmonary endothelial cells in vivo Microvasc Res 1997;54(2):135-44
96. Kam NW, Liu Z, Dai H. Carbon nanotubes as intracellular transporters for proteins and DNA: an investigation of the uptake mechanism and pathway. Angew Chem Int Ed Engl 2006;45(4):577-81
97. Jin H, Heller DA, Strano MS. Single-Particle Tracking of Endocytosis and Exocytosis of Single-Walled Carbon Nanotubes in NIH-3T3 Cells. Nano Lett 2008;8(6):1577-85
98. Kostarelos K, Lacerda L, Pastorin G, et al. cellular uptake of functionalized carbon nanotubes is independent of functional group and cell type. Nat Nanotechnol 2007;2(2):108-13
99. Beningo KA, Wang YL. Fc-receptor-mediated phagocytosis is regulated by mechanical properties of the target. J Cell Sci 2002;115(Pt 4):849-56.